KVP International Acquires SafePath-IVD (SafePath Laboratories & IVD Research)
December 12, 2025
KVP International has acquired SafePath Laboratories and IVD Research (together SafePath-IVD), a Carlsbad, California–based diagnostics manufacturer and CDMO with FDA, ISO 13485 and USDA licenses. KVP will use SafePath-IVD as its dedicated research, development and manufacturing partner to expand veterinary point-of-care diagnostics while supporting SafePath-IVD's continued growth in human diagnostics and CDMO services.
- Buyers
- KVP International
- Targets
- SafePath Laboratories, IVD Research
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
BioIVT Acquires Valley Biomedical Products & Services
June 28, 2021
Medical Devices
BioIVT, a provider of research models and value-added research services, has acquired Valley Biomedical Products & Services, an FDA-registered manufacturer of in vitro diagnostics, sera, plasma and reagents based in Winchester, Virginia. The acquisition will expand BioIVT’s capabilities in IVD manufacturing and cell & gene therapy support by combining Valley Biomedical’s reagent and blood-product manufacturing with BioIVT’s donor centers and specimen services; BioIVT will continue operating the Winchester facility and retain its staff.
-
SourceBio International plc Acquires LDPath Limited
March 29, 2022
Healthcare Services
SourceBio International plc has completed a strategic acquisition of LDPath Limited, a London-based digital pathology testing provider. The deal expands SourceBio's digital and AI-enabled pathology capabilities and creates a larger private provider of cellular and digital pathology services for the U.K. healthcare market.
-
VION Biosciences Acquires Ansh Labs
August 29, 2024
Biotechnology
VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Ansh Labs, an immunoassay development and reagent manufacturer based in Houston, Texas. The add-on expands VION's diagnostics capabilities — adding GMP IVD manufacturing and ISO 13485 certification — and broadens the platform's product and service offerings for clinical diagnostics, research, and pharmaceutical development.
-
Carmelina Capital Partners Invests in KVP International
July 11, 2024
Veterinary
Los Angeles-based private investment firm Carmelina Capital Partners has completed a growth investment in KVP International, a McKinney, Texas–headquartered manufacturer and supplier of veterinary and small-animal wellness products. KVP's CEO Ken Bowman will remain in place as the company pursues product innovation, capacity expansion and add-on acquisitions supported by Carmelina's capital and partnership.
-
BioIVT Acquires XenoTech from Sekisui Chemical
September 12, 2022
Biotechnology
BioIVT has acquired XenoTech, a Kansas City–based provider of ADME‑Tox in vitro models and contract research services, from Sekisui Chemical. The acquisition expands BioIVT's hepatic product portfolio and ADME/DMPK capabilities to better support biopharma customers' preclinical testing needs. Financial terms were not disclosed.
-
ARCHIMED Acquires BioVendor Group
March 11, 2025
Medical Devices
ARCHIMED, a Europe-focused private equity firm specializing in healthcare, has acquired BioVendor Group, a Brno-headquartered developer and manufacturer of in‑vitro diagnostics and immunoassays. ARCHIMED will partner with existing management to accelerate internationalization, product innovation and commercial expansion as part of its MED III fund's diagnostics investment strategy.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.